Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Saubermann

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Inflammatory Bowel Diseases|January 10, 2001
pANCA--is this your final answer?L J Saubermann
Inflammatory Bowel Diseases|May 25, 1999
Mesalamine: safe at first lookL J Saubermann, J L Wolf
Current Opinion in Immunology|January 13, 2000
Animal models of mucosal inflammation and their relation to human inflammatory bowel diseaseR S Blumberg, L J Saubermann, W Strober
Chemical Immunology|October 8, 1998
T-cell receptor usage in the intestineC S Probert, E W Aitken, L J Saubermann, et al.
Gastroenterology|October 21, 2000
Limited CD4 T-cell diversity associated with colitis in T-cell receptor alpha mutant mice requires a T helper 2 environmentA Mizoguchi, E Mizoguchi, L J Saubermann, et al.
Endoscopy|August 7, 1998
Duodenal variceal bleeding treated with a combination of endoscopic ligation and sclerotherapyF Omata, T Itoh, Y Shibayama, et al.
Journal of Clinical Immunology|May 3, 2001
Prevalence of an ulcerative colitis-associated CD8+ T cell receptor beta-chain CDR3-region motif and its association with disease activityC S Probert, A Chott, L J Saubermann, et al.
Immunology Letters|August 7, 1999
Antigen presentation by intestinal epithelial cellsR S Blumberg, W I Lencer, X Zhu, et al.
Gut|August 8, 2007
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel diseaseS Kugathasan, L J Saubermann, L Smith, et al.
The American Journal of Physiology|March 10, 1999
Evidence of T cell receptor beta-chain patterns in inflammatory and noninflammatory bowel disease statesL J Saubermann, C S Probert, A D Christ, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Inflammatory Bowel Diseases|January 10, 2001
pANCA--is this your final answer?L J Saubermann
Inflammatory Bowel Diseases|May 25, 1999
Mesalamine: safe at first lookL J Saubermann, J L Wolf
Current Opinion in Immunology|January 13, 2000
Animal models of mucosal inflammation and their relation to human inflammatory bowel diseaseR S Blumberg, L J Saubermann, W Strober
Chemical Immunology|October 8, 1998
T-cell receptor usage in the intestineC S Probert, E W Aitken, L J Saubermann, et al.
Gastroenterology|October 21, 2000
Limited CD4 T-cell diversity associated with colitis in T-cell receptor alpha mutant mice requires a T helper 2 environmentA Mizoguchi, E Mizoguchi, L J Saubermann, et al.
Endoscopy|August 7, 1998
Duodenal variceal bleeding treated with a combination of endoscopic ligation and sclerotherapyF Omata, T Itoh, Y Shibayama, et al.
Journal of Clinical Immunology|May 3, 2001
Prevalence of an ulcerative colitis-associated CD8+ T cell receptor beta-chain CDR3-region motif and its association with disease activityC S Probert, A Chott, L J Saubermann, et al.
Immunology Letters|August 7, 1999
Antigen presentation by intestinal epithelial cellsR S Blumberg, W I Lencer, X Zhu, et al.
Gut|August 8, 2007
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel diseaseS Kugathasan, L J Saubermann, L Smith, et al.
The American Journal of Physiology|March 10, 1999
Evidence of T cell receptor beta-chain patterns in inflammatory and noninflammatory bowel disease statesL J Saubermann, C S Probert, A D Christ, et al.
Pageof 2